310 related articles for article (PubMed ID: 37639166)
1. Zinc Oxide Nanoparticles and Cancer Chemotherapy: Helpful Tools for Enhancing Chemo-sensitivity and Reducing Side Effects?
Vaghari-Tabari M; Jafari-Gharabaghlou D; Mohammadi M; Hashemzadeh MS
Biol Trace Elem Res; 2024 May; 202(5):1878-1900. PubMed ID: 37639166
[TBL] [Abstract][Full Text] [Related]
2. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
[TBL] [Abstract][Full Text] [Related]
3. Zinc oxide nanoparticles: A comprehensive review on its synthesis, anticancer and drug delivery applications as well as health risks.
Singh TA; Das J; Sil PC
Adv Colloid Interface Sci; 2020 Dec; 286():102317. PubMed ID: 33212389
[TBL] [Abstract][Full Text] [Related]
4. Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology.
Xue X; Liang XJ
Chin J Cancer; 2012 Feb; 31(2):100-9. PubMed ID: 22237039
[TBL] [Abstract][Full Text] [Related]
5. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
6. Zinc overload mediated by zinc oxide nanoparticles as innovative anti-tumor agent.
Wiesmann N; Kluenker M; Demuth P; Brenner W; Tremel W; Brieger J
J Trace Elem Med Biol; 2019 Jan; 51():226-234. PubMed ID: 30115501
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.
Pérez-Tomás R
Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198
[TBL] [Abstract][Full Text] [Related]
8. Role of ABC transporters in cancer chemotherapy.
Sun YL; Patel A; Kumar P; Chen ZS
Chin J Cancer; 2012 Feb; 31(2):51-7. PubMed ID: 22257384
[TBL] [Abstract][Full Text] [Related]
9. Approaches for reducing chemo/radiation-induced cardiotoxicity by nanoparticles.
Li K; Chen W; Ma L; Yan L; Wang B
Environ Res; 2024 Mar; 244():117264. PubMed ID: 37776941
[TBL] [Abstract][Full Text] [Related]
10. ATP-binding cassette transporters in tumor endothelial cells and resistance to metronomic chemotherapy.
Hida K; Kikuchi H; Maishi N; Hida Y
Cancer Lett; 2017 Aug; 400():305-310. PubMed ID: 28216371
[TBL] [Abstract][Full Text] [Related]
11. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
[TBL] [Abstract][Full Text] [Related]
12. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin and folic acid-loaded zinc oxide nanoparticles-based combined anti-tumor and anti-inflammatory approach for enhanced anti-cancer therapy.
Gomaa S; Nassef M; Tabl G; Zaki S; Abdel-Ghany A
BMC Cancer; 2024 Jan; 24(1):34. PubMed ID: 38178054
[TBL] [Abstract][Full Text] [Related]
14. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L
Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876
[TBL] [Abstract][Full Text] [Related]
15. Berberine and zinc oxide-based nanoparticles for the chemo-photothermal therapy of lung adenocarcinoma.
Kim S; Lee SY; Cho HJ
Biochem Biophys Res Commun; 2018 Jun; 501(3):765-770. PubMed ID: 29758197
[TBL] [Abstract][Full Text] [Related]
16. Enhancing tumor chemotherapy and overcoming drug resistance through autophagy-mediated intracellular dissolution of zinc oxide nanoparticles.
Hu Y; Zhang HR; Dong L; Xu MR; Zhang L; Ding WP; Zhang JQ; Lin J; Zhang YJ; Qiu BS; Wei PF; Wen LP
Nanoscale; 2019 Jun; 11(24):11789-11807. PubMed ID: 31184642
[TBL] [Abstract][Full Text] [Related]
17. Zinc oxide nanoparticles for therapeutic purposes in cancer medicine.
Wiesmann N; Tremel W; Brieger J
J Mater Chem B; 2020 Jun; 8(23):4973-4989. PubMed ID: 32427264
[TBL] [Abstract][Full Text] [Related]
18. [Anticancer drugs and ABC transporters].
Oka M; Fukuda M; Soda H
Gan To Kagaku Ryoho; 2005 May; 32(5):585-92. PubMed ID: 15918555
[TBL] [Abstract][Full Text] [Related]
19. Use of arrays to investigate the contribution of ATP-binding cassette transporters to drug resistance in cancer chemotherapy and prediction of chemosensitivity.
Zhang JT
Cell Res; 2007 Apr; 17(4):311-23. PubMed ID: 17404598
[TBL] [Abstract][Full Text] [Related]
20. The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer.
Wang Y; Wang Y; Qin Z; Cai S; Yu L; Hu H; Zeng S
Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):291-306. PubMed ID: 33544643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
